Kandzari, D.E. Böhm, M. Mahfoud, F. Townsend, R.R. Weber, M.A. Pocock, S. Tsioufis, K. Tousoulis, D. Choi, J.W. East, C. Brar, S. Cohen, S.A. Fahy, M. Pilcher, G. Kario, K. Aoki, J. Batson, B. Böhm, M. Choi, J.W. Cohen, D.L. Dangas, G. David, S. Davies, J. Devireddy, C.M. Kandzari, D. Kario, K. Lee, D.P. Lurz, P.C. Papademetriou, V. Patel, M. Patel, K. Schmieder, R.E. Sharp, A.S.P. Singh, J. Tsioufis, K. Walton, A. Weber, T. Weil, J. Zeller, T. Ziada, K. Tanabe, K. Wilkins, R. Mahfoud, F. East, C. Wilensky, R. Contreras, J. Steigerwalt, S. Chapman, N. Lea, J.P. Reedus, D. Hoshide, S. Ma, A. Fengler, K. Li, P. Svetkey, L. Rao, A. Schmid, A. Watkinson, A.F. Brown, A. Tousoulis, D. Hopper, I. Suppan, M. Agdirlioglu, T. Noory, E. Chasen, C. SPYRAL HTN-ON MED Trial Investigators, Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial, The Lancet Neurology, (391), 2346-2355, 2018, The Lancet Publishing Group,